Related by context. Frequent words. (Click for all words.) 65 Mark A. Sirgo 65 Dr. Randall Yatscoff 65 Juergen Engel Ph.D. 63 Barry D. Quart 62 Steve Worland Ph.D. 61 Mr. Rosconi 59 David Aviezer 59 NASDAQ DYAX 59 Michael H. Tardugno 59 Ampio 59 Brian JG Pereira 59 Completes Patient Enrollment 58 www.spectrumpharm.com 57 Kiadis Pharma 57 David H. Fater 57 Genaera Corporation 57 www.delcath.com 57 www.BMRN.com 57 Æterna Zentaris 57 ImmunoCellular Therapeutics 57 Lonnie Moulder 56 Lung Rx 56 Nasdaq GERN 56 Jumps Higher 56 J. Donald deBethizy 56 Nasdaq ADLR 56 Mr. Fater 55 Nasdaq OSIP 55 MERLIN TIMI 55 OGXI 55 Lifts FY# Outlook 55 TSX TLN 55 Receives Orphan Drug Designation 55 Simon Sturge 55 Q2 Loss Narrows 55 NASDAQ CYPB 55 TIMI Study Group 55 Clay B. Siegall 55 Dino Dina 55 MAA submission 55 Plicera 54 MEND CABG II 54 MultiCell Technologies 54 Kauffman MD Ph.D. 54 Fibrillex TM 54 http:/www.nabi.com 54 Sol J. Barer 54 IIa trial 54 ATACAND 54 PEG SN# 54 Patient Enrollment 54 Backs FY# Outlook 54 By Katy Burne 54 Welcomes Analyst Initiation 54 Francois Nader 54 Inc Therapeutic Competitors 53 Files Shelf Registration Statement 53 plc NASDAQ AMRN 53 By ALICIA GALLEGOS 53 JNJ Q2 53 NASDAQ IPXL today 53 Cell Sci 53 Chief ExecutiveOfficer 53 Dr. Francesco Bellini 53 OncoGenex Pharmaceuticals 53 eprotirome 53 Neogenix 53 G. Simmonds 53 deforolimus 53 L. Surratt 53 Trofex 53 Inovio Pharmaceuticals 53 Relivar 53 By Mitch Hotts 53 Keryx Biopharmaceuticals 53 enzastaurin 53 PSMA ADC 53 CR# vcMMAE 53 www.infinera.com 53 BrachySil TM 53 DeveloGen 52 Gilles Gagnon 52 Announces Adjournment 52 Q3 Loss Narrows 52 Q4 Loss Narrows 52 L. Krall 52 immatics 52 Paul Cofoni CACI 52 Joel F. Gemunder 52 Onno van de Stolpe 52 Panzem R NCD 52 Shareholders Approve Acquisition 52 NASDAQ MYGN 52 Aegerion 52 Enobia 52 SCOLR Pharma 52 www.ipgphotonics.com 52 Phase Ib study 52 tanespimycin 52 http:/www.viropharma.com 52 huC# DM4